|
[1]
|
Aniskevich S, Leone BJ, Brull SJ. Sugammadex:a novel approach to reversal of neuromuscular blockade[J]. Expert Rev Neurother, 2011,11(2):185. |
|
[2]
|
Lee C. Goodbye suxamethonium[J]. Anaesthesia, 2009,64(Suppl. 1):73. |
|
[3]
|
Schultz P, Ibsen M, φstergaard D, et al. Onset and duration of action of rocuronium-from tracheal intubation, through intense block to complete recovery[J]. Acta Anaesthesiol Scand, 2001,45(5):612. |
|
[4]
|
Kopman AF, Zhaku B, Lai KS. The "intubating dose" of succinylcholine:the effect of decreasing doses on recovery time[J]. Anesthesiology, 2003,99(5):1050. |
|
[5]
|
Perry JJ, Lee JS, Sillberg VA, et al. Rocuronium versus succinylcholine for rapid sequence induction intubation[J]. Cochrane Database Syst Rev, 2008,2:CD002788. |
|
[6]
|
McTernan CN, Rapeport DA, Ledowski T. Successful use of rocuronium and sugammadex in an anticipated difficult airway scenario[J]. Anaesth Intensive Care,2010,38(2):390. |
|
[7]
|
闻大翔,欧阳葆怡,杭燕南. 肌肉松弛药[M]. 上海:世界图书出版公司,2007:1. |
|
[8]
|
Jones RK, Caldwell JE, Brull SJ, et al. Reversal of profound rocuronium induced blockade with sugammadex:a randomized comparison with neostigmine[J].Anesthesiology,2008, 109(5):816. |
|
[9]
|
Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia[J]. Anesthesiology, 2010,112(4):1013. |
|
[10]
|
McDonnell NJ, Pavy TJ, Green LK. Sugammadex in the management of rocuronium-induced anaphylaxis[J]. Br J Anaesth, 2011,106(2):199. |
|
[11]
|
Plaud B, Meretoja O, Hofmockel R, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients[J]. Anesthesiology, 2009, 110(2):284. |
|
[12]
|
Suzuki T, Kitajima O, Ueda K, et al. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients[J]. Br J Anaesth, 2011,106(6):823. |
|
[13]
|
Monk T. Obesity has no clinically relevant impact upon recovery time following administration of sugammadex[C]. Presented at Annual Meeting of American Society of Anesthesiologists. Orlando:2008. Abstract A682. |
|
[14]
|
Desforges JC, McDonnell NJ. Sugammadex in the management of a failed intubation in a morbidly obese patient[J]. Anaesth Intensive Care, 2011,39(4):763. |
|
[15]
|
Van Lancker P, Dillemans B, Bogaert T, et al. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients[J]. Anaesthesia, 2011,66(8):721. |
|
[16]
|
Sharp LM, Levy DM. Rapid sequence induction in obstetrics revisited[J]. Curr Opin Anaesthesiol, 2009,22(3):357 |
|
[17]
|
Puhringer FK, Kristen P, Rex C. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients:a series of seven cases[J]. Br J Anaesth, 2010, 105(5):657. |
|
[18]
|
Williamson RM, Mallaiah S, Barclay P. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia[J]. Acta Anaesthesiol Scand, 2011, 55:694. |
|
[19]
|
Robertson EN, Driessen JJ, Booij LH. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure[J]. Eur J Anaesthesiol, 2005,22(1):4. |
|
[20]
|
Yentis SM. Suxamethonium and hyperkalaemia[J]. Anaesth Intensive Care, 1990, 18(1):92. |
|
[21]
|
Staals LM, Snoeck MM, Driessen JJ, et al. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function[J]. Br J Anaesth, 2008,101(4):492. |
|
[22]
|
Porter MV, Paleologos MS. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal[J]. Anaesth Intensive Care, 2011, 39(2):299. |
|
[23]
|
Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis[J]. Anaesthesia, 2010, 65(3):302. |
|
[24]
|
Matsuki Y, Hirose M, Tabata M, et al. The use of sugammadex in a patient with myotonic dystrophy[J].Eur J Anaesthesiol,2010,28(2):145. |
|
[25]
|
de Boer HD, van Esmond J, Booij LH, et al. Reversal of rocuronium induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy[J]. Paediatr Anaesth, 2009, 19(12):1226 |
|
[26]
|
Cammu G, De Kam PJ, Demeyer I, et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers[J]. Br J Anaesth, 2008, 100(3):373 |
|
[27]
|
de Kam PJ, van Kuijk J, Prohn M, et al. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuroniumor vecuroniumon QTc prolongation:a thorough QTc study[J]. Clin Drug Investig, 2010, 30(9):599. |
|
[28]
|
Peeters PA, Michiel W,Heuvel VD, et al. Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects:a randomized,double-blind, crossover, placebo-controlled, single-centre study[J]. Clin Drug Investig, 2010, 30(12):867. |
|
[29]
|
Menendez-Ozcoidi L, Ortiz-Gómez JR. Olaguibel-Ribero JM, et al. Allergy to low dose sugammadex[J]. Anaesthesia, 2011, 66(3), 217. |
|
[30]
|
Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block:a systematic review and economic evaluation[J]. Br J Anaesth, 2010, 105(5):558. |
点击查看大图
下载:
